Form 10-Q OCULAR THERAPEUTIX, INC For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Ocular Therapeutix (OCUL) Misses Q3 EPS by 9c
November 10, 2015 4:35 PM ESTOcular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.47), $0.09 worse than the analyst estimate of ($0.38).
The third quarter 2015 results include $1.2 million in non-cash charges for stock-based compensation compared to $0.6 million in the third quarter of 2014.
As of September 30, 2015, cash and cash equivalents and marketable... More
